Literature DB >> 17621673

Acute myocardial infarction and underlying stenosis severity.

Ole Frøbert1, Marcel van't Veer, Wilbert Aarnoudse, Ulf Simonsen, Jacques J Koolen, Nico H J Pijls.   

Abstract

OBJECTIVES: The objective of this study was to investigate the underlying stenosis severity of the culprit lesion in acute myocardial infarction.
BACKGROUND: It is widely believed that myocardial infarction often occurs in angiographically mild luminal stenosis. This, however, is in contradiction with experience from interventional practice in primary PCI.
METHODS: We performed quantitative coronary angiography (QCA) in 250 consecutive patients referred for acute percutaneous coronary intervention (PCI) because of acute myocardial infarction (AMI). Fundamental for analysis was that a realistic estimate of underlying luminal narrowing before the infarction could be made angiographically that QCA could be performed and that one of two criteria was met: (1) spontaneous reflow allowing assessment of the lumen proximal and distal to the culprit lesion, or (2) coronary artery closed at arrival but reflow after uncomplicated wiring allowing assessment of the lumen proximal and distal to the culprit lesion.
RESULTS: Of 250 consecutive patients (mean age 61.7 +/- 12.7 years, 48 women) referred for acute PCI, 156 patients (62%) fulfilled at least one of the above criteria for reliable QCA. In 151 of these patients (96%) the severity of the underlying stenosis was >50% and in 103 (66%) it was >70%. There were no differences in stenosis severity between the left anterior descending [LAD, (72 +/- 13)%, n = 57], left circumflex [Cx, (74 +/- 10)%, n = 20], and right coronary artery territory [RCA, (74 +/- 12)%, n = 76] (ANOVA, P = 0.76). There were no differences in stenosis severity between women [(73 +/- 13)%, n = 36] and men [(75 +/- 11)%, n = 120; P = 0.35].
CONCLUSION: In contrast to what is often believed, the majority of myocardial infarctions occurs in significant stenosis. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17621673     DOI: 10.1002/ccd.21280

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  13 in total

1.  Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease.

Authors:  Gjin Ndrepepa; Tomohisa Tada; Massimiliano Fusaro; Salvatore Cassese; Lamin King; Martin Hadamitzky; Hans-Ullrich Haase; Albert Schömig; Adnan Kastrati; Jürgen Pache
Journal:  Clin Res Cardiol       Date:  2012-07-08       Impact factor: 5.460

2.  Correlation between monocyte chemoattractant protein-1/chemokine (C-C motif) ligand 2 and coronary plaque characteristics.

Authors:  Meng Li; Yan Chen; Yan Zhang; Danna Li; Jun Liu
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-08

3.  Non-invasive detection of vulnerable coronary plaque.

Authors:  Faisal Sharif; Derek G Lohan; William Wijns
Journal:  World J Cardiol       Date:  2011-07-26

4.  High-grade culprit lesions are a common cause of ST-segment elevation myocardial infarction.

Authors:  Michael Liang; Takashi Kajiya; Mark Y Chan; Edgar Tay; Chi-Hang Lee; Arthur Mark Richards; Adrian F Low; Huay Cheem Tan
Journal:  Singapore Med J       Date:  2015-06       Impact factor: 1.858

5.  The Relationship between Coronary Artery Movement Type andStenosis Severity with Acute Myocardial Infarction.

Authors:  Samad Ghaffari; Siamak Erfanparast; Ahmad Separham; Sepideh Sokhanvar; Mehrdad Yavarikia; Leili Pourafkari
Journal:  J Cardiovasc Thorac Res       Date:  2013-06-27

Review 6.  The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment.

Authors:  Armin Arbab-Zadeh; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2015-01-16       Impact factor: 24.094

7.  Stenting versus non-stenting treatment of intermediate stenosis culprit lesion in acute ST-segment elevation myocardial infarction: a multicenter randomized clinical trial.

Authors:  Jing Dai; Shu-Zheng Lyu; Yun-Dai Chen; Xian-Tao Song; Min Zhang; Wei-Min Li; Yang Zheng; Shang-Yu Wen; Shao-Ping Nie; Yu-Jie Zeng; Hai Gao; Yi-Tong Ma; Shu-Yang Zhang; Li-Jun Guo; Zheng Zhang
Journal:  J Geriatr Cardiol       Date:  2017-02       Impact factor: 3.327

8.  A score to quantify coronary plaque vulnerability in high-risk patients with type 2 diabetes: an optical coherence tomography study.

Authors:  Mathias Burgmaier; Martin Hellmich; Nikolaus Marx; Sebastian Reith
Journal:  Cardiovasc Diabetol       Date:  2014-08-21       Impact factor: 9.951

9.  Cardiac Usage of Reducible Poly(oligo-D-arginine) As a Gene Carrier for Vascular Endothelial Growth Factor Expression.

Authors:  Jongsu Woo; Seong-Ho Bae; Bokyoung Kim; Jin Sil Park; Subin Jung; Minhyung Lee; Yong-Hee Kim; Donghoon Choi
Journal:  PLoS One       Date:  2015-12-09       Impact factor: 3.240

10.  Presence of Severe Stenosis in Most Culprit Lesions of Patients with ST-segment Elevation Myocardial Infarction.

Authors:  Li Sheng; Shuang Li; Jian-Qiang Li; Jing-Yi Xue; Yan-Ming Sun; Yong-Tai Gong; Ling Jing; Dang-Hui Sun; Wei-Min Li; Ding-Yu Wang; Yue Li
Journal:  Chin Med J (Engl)       Date:  2016-09-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.